ArticleEBioMedicine2022

Epigenetic landscape in the kick-and-kill therapeutic vaccine BCN02 clinical trial is associated with antiretroviral treatment interruption (ATI) outcome.

Bruna Oriol-Tordera et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.